Cargando…

The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis

BACKGROUND: For patients with hepatocellular carcinoma (HCC) with microvascular invasion (MVI) after curative resection, the effects of various postoperative adjuvant therapies are not summarized in detail, and the comparison between the effects of various adjuvant therapies is still unclear. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jiarui, Liang, Hao, Hu, Kunpeng, Xiong, Zhiyong, Cao, Mingbo, Zhong, Zhaozhong, Yao, Zhicheng, Deng, Meihai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868028/ https://www.ncbi.nlm.nih.gov/pubmed/33549093 http://dx.doi.org/10.1186/s12935-021-01790-6

Ejemplares similares

Identification of miRNAs as diagnostic and prognostic markers in hepatocellular carcinoma
por: Liang, Hao, et al.
Publicado: (2021)

BDH2 is downregulated in hepatocellular carcinoma and acts as a tumor suppressor regulating cell apoptosis and autophagy
por: Liang, Hao, et al.
Publicado: (2019)

Postoperative adjuvant therapy for hepatocellular carcinoma with microvascular invasion
por: Li, Jiang, et al.
Publicado: (2023)

Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma
por: Yao, Zhicheng, et al.
Publicado: (2020)

Postoperative adjuvant radiotherapy is associated with improved survival in hepatocellular carcinoma with microvascular invasion
por: Wang, Liming, et al.
Publicado: (2017)

Laparoscopic RFA with splenectomy for hepatocellular carcinoma
por: Hu, Kunpeng, et al.
Publicado: (2016)

Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy
por: Dai, Mu-Gen, et al.
Publicado: (2023)

Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
por: Ye, Jia-Zhou, et al.
Publicado: (2017)

A Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatocellular Carcinoma: Single-Center Analyses With Internal Validation
por: Yang, Jiarui, et al.
Publicado: (2021)

Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
por: Wei, Wei, et al.
Publicado: (2018)

A Nomogram Predicting Microvascular Invasion Risk in BCLC 0/A Hepatocellular Carcinoma after Curative Resection
por: Gao, Shuai-Xiang, et al.
Publicado: (2019)

Identification and Validation of a Prognostic Model Based on Three MVI-Related Genes in Hepatocellular Carcinoma
por: Tang, Yongchang, et al.
Publicado: (2022)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

Prognostic and Clinicopathological Value of PINX1 in Various Human Tumors: A Meta-Analysis
por: Liang, Hao, et al.
Publicado: (2018)

Effects of microvascular invasion on clinical outcomes after resection with curative intent for cholangiocarcinoma
por: Song, Bo-Hye, et al.
Publicado: (2020)

Postoperative adjuvant transarterial chemoembolisation improves survival of hepatocellular carcinoma patients with microvascular invasion: A multicenter retrospective cohort
por: Luo, Laihui, et al.
Publicado: (2023)

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study
por: Li, Shao-Hua, et al.
Publicado: (2023)

Inhibition of cyclin E1 sensitizes hepatocellular carcinoma cells to regorafenib by mcl-1 suppression
por: Xu, Jianliang, et al.
Publicado: (2019)

Development and validation of prognostic dynamic nomograms for hepatitis B Virus-related hepatocellular carcinoma with microvascular invasion after curative resection
por: Bai, Shilei, et al.
Publicado: (2023)

Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study
por: Wang, Liming, et al.
Publicado: (2020)

Adjuvant therapy following curative treatments for hepatocellular carcinoma: current dilemmas and prospects
por: Guo, Bin, et al.
Publicado: (2023)

Preoperative and postoperative nomograms for predicting early recurrence of hepatocellular carcinoma without macrovascular invasion after curative resection
por: Zhang, Yanfang, et al.
Publicado: (2022)

Network meta-analysis of adjuvant treatments for patients with hepatocellular carcinoma after curative resection
por: Ye, Yanyan, et al.
Publicado: (2023)

Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection
por: Zhou, Yan-Ming, et al.
Publicado: (2015)

Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis
por: Wang, Liming, et al.
Publicado: (2019)

Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy?
por: Huang, Yun, et al.
Publicado: (2019)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

Prognostic Nomograms Combined Adjuvant Lenvatinib for Hepatitis B Virus–related Hepatocellular Carcinoma With Microvascular Invasion After Radical Resection
por: Bai, Shilei, et al.
Publicado: (2022)

The clinical significance of microvascular invasion in the surgical planning and postoperative sequential treatment in hepatocellular carcinoma
por: Wang, Wentao, et al.
Publicado: (2021)

Lnc-ZEB2-19 Inhibits the Progression and Lenvatinib Resistance of Hepatocellular Carcinoma by Attenuating the NF-κB Signaling Pathway through the TRA2A/RSPH14 Axis
por: Cao, Mingbo, et al.
Publicado: (2023)

The Comparison of Surgical Margins and Type of Hepatic Resection for Hepatocellular Carcinoma With Microvascular Invasion
por: Liu, Jianwei, et al.
Publicado: (2023)

Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection
por: Chen, Jian-Lin, et al.
Publicado: (2016)

Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
por: Wu, LinWei, et al.
Publicado: (2012)

Identification of the hsa_circ_0039466/miR-96-5p/FOXO1 regulatory network in hepatocellular carcinoma by whole-transcriptome analysis
por: Yuan, Feng, et al.
Publicado: (2022)

Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”
por: Tang, Xiao-Long, et al.
Publicado: (2022)

Radiomics for the detection of microvascular invasion in hepatocellular carcinoma
por: Lv, Kun, et al.
Publicado: (2022)

Adjuvant atezolizumab-bevacizumab after curative therapy for hepatocellular carcinoma
por: Kudo, Masatoshi
Publicado: (2023)

Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
por: Hisashige, Akinori, et al.
Publicado: (2013)

Adjuvant chemotherapy in curatively resected rectal cancer: How valid are the data?
por: Manzini, Giulia, et al.
Publicado: (2020)

Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
por: Chen, Ming-Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2tnj4en150ihvrfrjdj05ethme